These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 9848971)

  • 1. Pap smear screening at an urban aboriginal health service: report of a practice audit and an evaluation of recruitment strategies.
    Hunt JM; Gless GL; Straton JA
    Aust N Z J Public Health; 1998 Oct; 22(6):720-5. PubMed ID: 9848971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmentation of Pap smear screening of high risk aboriginal women. Use of a computerised process tool within the Broome Aboriginal Medical Service.
    Couzos S; Wronski I; Murray R; Cox H
    Aust Fam Physician; 1998 Apr; 27(4):269-74. PubMed ID: 9581335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A community-based cervical screening program in a remote Aboriginal community in the Northern Territory.
    Gilles MT; Crewe S; Granites IN; Coppola A
    Aust J Public Health; 1995 Oct; 19(5):477-81. PubMed ID: 8713197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
    Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
    Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mobile unit: an effective service for cervical cancer screening among rural Thai women.
    Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Tatip Y; Boonmak C
    Int J Epidemiol; 1999 Feb; 28(1):35-9. PubMed ID: 10195661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast and cervical cancer screening in obese minority women.
    Ferrante JM; Chen PH; Jacobs A
    J Womens Health (Larchmt); 2006 Jun; 15(5):531-41. PubMed ID: 16796480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pap smear screening, pap smear abnormalities and psychosocial risk factors among women in a residential alcohol and drug rehabilitation facility.
    Soccio J; Brown M; Comino E; Friesen E
    J Adv Nurs; 2015 Dec; 71(12):2858-66. PubMed ID: 26279461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Fitzroy Valley Pap Smear Register. Cervical screening in a population of Australian aboriginal women.
    Mak DB; Straton JA
    Med J Aust; 1993 Feb; 158(3):163-6. PubMed ID: 8450781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving cervical screening in a remote aboriginal community.
    Reath J; Usherwood T
    Aust N Z J Public Health; 1998 Oct; 22(6):659-63. PubMed ID: 9848959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a mobile unit on changes in knowledge and use of cervical cancer screening among rural Thai women.
    Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Lerdlukanavonge P; Koonchote S
    Int J Epidemiol; 1995 Jun; 24(3):493-8. PubMed ID: 7672887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomised controlled trial of strategies to prompt attendance for a Pap smear.
    Bowman J; Sanson-Fisher R; Boyle C; Pope S; Redman S
    J Med Screen; 1995; 2(4):211-8. PubMed ID: 8719151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pap smear preceptor program.
    Harris-Bray S
    Aust Nurs Midwifery J; 2014 Apr; 21(9):42. PubMed ID: 24812782
    [No Abstract]   [Full Text] [Related]  

  • 13. Barriers and missed opportunities in breast and cervical cancer screening among women aged 50 and over, New York City, 2002.
    Nash D; Chan C; Horowitz D; Vlahov D
    J Womens Health (Larchmt); 2007; 16(1):46-56. PubMed ID: 17324096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
    Nygård JF; Skare GB; Thoresen SØ
    J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving cervical cytology screening in a remote, high risk population.
    Shield PW; Nolan GR; Phillips GE; Cummings MC
    Med J Aust; 1999 Mar; 170(6):255-8. PubMed ID: 10212646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How reminders given to patients and physicians affected pap smear use in a health maintenance organization: results of a randomized controlled trial.
    Burack RC; Gimotty PA; George J; McBride S; Moncrease A; Simon MS; Dews P; Coombs J
    Cancer; 1998 Jun; 82(12):2391-400. PubMed ID: 9635532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer of the uterine cervix and screening of Aboriginal women.
    Guest C; Mitchell H; Plant A
    Aust N Z J Obstet Gynaecol; 1990 Aug; 30(3):243-7. PubMed ID: 2256865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case study of the effectiveness of nurse-led screening programmes for cervical cancer among Hong Kong Chinese women.
    Twinn S; Cheng F
    J Adv Nurs; 1999 May; 29(5):1089-96. PubMed ID: 10320491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving adherence to screening follow-up among women with abnormal Pap smears: results from a large clinic-based trial of three intervention strategies.
    Marcus AC; Crane LA; Kaplan CP; Reading AE; Savage E; Gunning J; Bernstein G; Berek JS
    Med Care; 1992 Mar; 30(3):216-30. PubMed ID: 1538610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening HMO women overdue for both mammograms and pap tests.
    Valanis BG; Glasgow RE; Mullooly J; Vogt TM; Whitlock EP; Boles SM; Smith KS; Kimes TM
    Prev Med; 2002 Jan; 34(1):40-50. PubMed ID: 11749095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.